NTG Nordic Transport Group Annual Report for 2022
Company announcement no. 5 – 238 March 2023 NTG Nordic Transport Group Annual Report for…
Company announcement no. 5 – 238 March 2023 NTG Nordic Transport Group Annual Report for…
Company announcement no. 5 – 238 March 2023 NTG Nordic Transport Group Annual Report for…
CH Trading Group will serve as exclusive territories distributor in the Middle East and North…
CH Trading Group will serve as exclusive territories distributor in the Middle East and North…
NEW YORK, March 08, 2023 (GLOBE NEWSWIRE) — Intelligent Bio Solutions Inc. (Nasdaq: INBS) (the…
NEW YORK, March 07, 2023 (GLOBE NEWSWIRE) — Intelligent Bio Solutions Inc. (Nasdaq: INBS) (the…
SAN DIEGO and GAINESVILLE, Ga., March 03, 2023 (GLOBE NEWSWIRE) — Societal CDMO, Inc. (“Societal…
Sassy Little Box Program Powered by binx everywhere Digital Platform & Logistics Makes At-Home Self-Collection…
Sassy Little Box Program Powered by binx everywhere Digital Platform & Logistics Makes At-Home Self-Collection…
NEW YORK, March 01, 2023 (GLOBE NEWSWIRE) — Intelligent Bio Solutions Inc. (“Intelligent Bio Solutions”…
NEW YORK, March 01, 2023 (GLOBE NEWSWIRE) — Intelligent Bio Solutions Inc. (“Intelligent Bio Solutions”…
LEIDEN, Netherlands & CAMBRIDGE, Mass., Feb. 28, 2023 (GLOBE NEWSWIRE) — ProQR Therapeutics N.V. (Nasdaq:…
Company Focuses on Development of Neuromuscular Blocking Agents Phase II Randomized Trial for BX1000 Initiated,…
Webcast Scheduled for Wednesday, March 1, 2023, at 4:30 p.m. Eastern SAN DIEGO and GAINESVILLE,…
– 513(g) submission will allow Intelligent Bio Solutions Inc. to determine the most suitable FDA…
– Second quarter total revenue and government support income increased over 100% year-over-year – –…
Pre-launch commercial activities underway as Company advances toward U.S. Food and Drug Administration (FDA) Prescription…
NEW YORK, Feb. 09, 2023 (GLOBE NEWSWIRE) — Intelligent Bio Solutions Inc. (Nasdaq: INBS) (“Intelligent…
ORION CORPORATION FINANCIAL STATEMENT RELEASE 2022 9 FEBRUARY 2023 at 12:00 EET Orion Group Financial Statement Release 2022…
– Russ Trenary, President and Chief Executive Officer of Outlook Therapeutics to present on Tuesday,…